Fundamental Valuation Report Vaxart(VXRT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.70 (USD) 05/21/2021 Weighted Valuation$6.34 (USD) Overall RatingOvervalued by 5.4% Valuation Models Comparables: $6.34 (USD) Valuation Methods This …
Vaxart (VXRT:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Voyager Therapeutics(VYGR:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.26 (USD) 05/21/2021 Weighted Valuation$6.09 (USD) Overall RatingUndervalued by 43.0% Valuation Models Discounted Cash Flow: $6.10 (USD) …
Voyager Therapeutics (VYGR:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Provention Bio(PRVB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.80 (USD) 05/12/2021 Weighted Valuation$12.62 (USD) Overall RatingUndervalued by 85.5% Valuation Models Comparables: $12.94 (USD) Adjusted Book …
Provention Bio (PRVB:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report PTC Therapeutics(PTCT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$38.29 (USD) 05/12/2021 Weighted Valuation$38.22 (USD) Overall RatingFairly valued to slightly Overvalued by 0.2% Valuation Models Multiples: $33.22 …
PTC Therapeutics (PTCT:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Arcus Biosciences(RCUS:NYS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$29.15 (USD) 05/12/2021 Weighted Valuation$34.57 (USD) Overall RatingUndervalued by 18.6% Valuation Models Comparables: $34.57 (USD) Valuation Methods …
Arcus Biosciences (RCUS:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Madrigal Pharmaceuticals(MDGL:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$126.71 (USD) 05/06/2021 Weighted Valuation$113.33 (USD) Overall RatingOvervalued by 10.6% Valuation Models Comparables: $95.62 (USD) Valuation Methods …
Madrigal Pharmaceuticals (MDGL:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report MannKind(MNKD:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.29 (USD) 05/07/2021 Weighted Valuation$3.95 (USD) Overall RatingOvervalued by 7.9% Valuation Models Comparables: $2.59 (USD) Valuation Methods This …
MannKind (MNKD:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Kala Pharmaceuticals(KALA:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.45 (USD) 05/04/2021 Weighted Valuation$6.67 (USD) Overall RatingFairly valued to slightly Undervalued by 3.4% Valuation Models Adjusted …
Kala Pharmaceuticals (KALA:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Intra-Cellular Therapies(ITCI:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$34.43 (USD) 04/30/2021 Weighted Valuation$26.38 (USD) Overall RatingOvervalued by 23.4% Valuation Models Comparables: $26.38 (USD) Valuation Methods …
Intra-Cellular Therapies (ITCI:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Jounce Therapeutics(JNCE:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$9.43 (USD) 04/30/2021 Weighted Valuation$10.14 (USD) Overall RatingUndervalued by 7.5% Valuation Models Adjusted Book Value: $10.14 (USD) …
Jounce Therapeutics (JNCE:NAS) Fundamental Valuation Report Read more »
Read More